Tamoxifen’s Impact on Lipid Profiles in American Male Breast Cancer Patients: A Cohort Study
Reading Time: 3 minutesIntroduction Breast cancer, though less common in men than in women, presents unique challenges and treatment considerations. Tamoxifen, a selective estrogen receptor modulator (SERM), is a cornerstone of adjuvant therapy for both male and female breast cancer patients. While its efficacy in reducing cancer recurrence is well-documented, the impact of Tamoxifen on lipid profiles in male patients warrants further exploration.... Read more »
